XİNRAN WU, SHUANG ZHANG, JUNHUİ LAİ, HUİDİ LU, YUCHEN SUN, WEİJUN GUAN
Experimental and Clinical Transplantation - 2020;18(7):823-831
Objectives: Liver fibrosis is inevitable in the healing process of liver injury. Liver fibrosis will develop into liver cirrhosis unless the damaging factors are removed. This study investigated the potential therapy of Bama pig adipose-derived mesenchymal stem cells in a carbon tetrachloride-induced liver fibrosis Institute of Cancer Research strain mice model. Materials and Methods: Adipose-derived mesenchymal stem cells were injected intravenously into the tails of mice of the Institute of Cancer Research strain that had been treated with carbon tetrachloride for 4 weeks. Survival rate, migration, and proliferation of adiposederived mesenchymal stem cells in the liver were observed by histochemistry, fluorescent labeling, and serological detection. Results: At 1, 2, and 3 weeks after adipose-derived mesenchymal stem cell injection, liver fibrosis was significantly ameliorated. The injected adiposederived mesenchymal stem cells had hepatic differentiation potential in vivo, and the survival rate of adipose-derived mesenchymal stem cells declined over time. Conclusions: The findings in this study confirmed that adipose-derived mesenchymal stem cells derived from the Bama pig can be used in the treatment of liver fibrosis, and the grafted adipose-derived mesenchy - mal stem cells can migrate, survive, and differentiate into hepatic cells in vivo.
